The use of CIT at the time of biologic induction in the treatment of IBD has been shown to decrease the risk of ADA formation and improve therapeutic drug levels and drug durability in both adult and pediatric populations.4, 7, 8. The gene discussed is ADA; the disease is inflammatory bowel disease.